Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dis-Chem PharmaciesJSE:DCP -0.36%87 Return-on-Tangible-Asset is 3.76% as of Feb. 2026, which is 45% below its 10-year median of 6.87. GuruFocus rates JSE:DCP with a GF Score™ of 87/100 and a GF Value™ of R38.34 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 680 Healthcare Providers & Services companies, Dis-Chem Pharmacies ranks better than 64.71% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Dis-Chem Pharmacies's annualizedNet Income for the quarter that ended in Feb. 2026 was R692 Mil. Dis-Chem Pharmacies's average total tangible assets for the quarter that ended in Feb. 2026 was R18,406 Mil. Therefore, Dis-Chem Pharmacies's annualized Return-on-Tangible-Asset for the quarter that ended in Feb. 2026 was 3.76%.
The historical rank and industry rank for Dis-Chem Pharmacies's Return-on-Tangible-Asset or its related term are showing as below:
JSE:DCP'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 5.32 Med: 6.87 Max: 11.14
Current: 5.38
During the past 13 years, Dis-Chem Pharmacies's highest Return-on-Tangible-Asset was 11.14%. The lowest was 5.32%. And the median was 6.87%.
JSE:DCP's Return-on-Tangible-Asset is ranked better than 64.71% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 2.465
vs JSE:DCP: 5.38
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Dis-Chem Pharmacies Return-on-Tangible-Asset Related Terms
Dis-Chem Pharmacies Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Dis-Chem Pharmacies's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dis-Chem Pharmacies Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Dis-Chem Pharmacies's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Feb. 2026) net income data.
What does a Return-on-Tangible-Asset of 3.76% mean?
Dis-Chem Pharmacies (JSE:DCP) has a Return-on-Tangible-Asset of 3.76% as of Feb. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Dis-Chem Pharmacies and its competitors. This is 45% below median its historical median of 6.87. Over the past decade, Dis-Chem Pharmacies' Return-on-Tangible-Asset has ranged from 5.32 to 11.14. According to the industry distribution chart, Dis-Chem Pharmacies ranks #240 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 35.3%.
Is Dis-Chem Pharmacies' Return-on-Tangible-Asset too high?
Dis-Chem Pharmacies' current Return-on-Tangible-Asset of 3.76% is 45% below median its 10-year median of 6.87. Over the past 10 years, this metric has ranged from a low of 5.32 to a high of 11.14. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.47. Dis-Chem Pharmacies' value of 3.76% is 52.5% above this industry median. Based on the distribution chart, Dis-Chem Pharmacies ranks #240 out of 680 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dis-Chem Pharmacies has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' Return-on-Tangible-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dis-Chem Pharmacies ranks #240 out of 680 companies for Return-on-Tangible-Asset. This puts Dis-Chem Pharmacies in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.47. Dis-Chem Pharmacies' value of 3.76% is 52.5% above this benchmark. Historically, Dis-Chem Pharmacies' own Return-on-Tangible-Asset has ranged from 5.32 to 11.14 over the past decade. While the company's 10-year median is 6.87 vs. the industry median of 2.47, Dis-Chem Pharmacies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.47, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dis-Chem Pharmacies's current Return-on-Tangible-Asset of 3.76% is 52.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Dis-Chem Pharmacies and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dis-Chem Pharmacies's current Return-on-Tangible-Asset is 3.76%, which is 45% below median its own 10-year median of 6.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.34, compared to a current price of R30.19 — trading 21.3% below its estimated fair value. The current Return-on-Tangible-Asset is 3.76%, which is 45% below median its 10-year median of 6.87 and 52.5% above the Healthcare Providers & Services industry median of 2.47. Dis-Chem Pharmacies' overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current Return-on-Tangible-Asset is 3.76% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?
Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued.
The current stock price of R30.19 is trading 21.3% below its estimated GF Value™ of R38.34.
GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.
Key valuation signals for JSE:DCP:
Return-on-Tangible-Asset: 3.76% (45% below median its 10-year median of 6.87)
GF Value™: R38.34 vs. price of R30.19 (21.3% below fair value)
Industry Position: 52.5% above the Healthcare Providers & Services median (#240 of 680)
No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
87GF Score
Get the complete analysis for JSE:DCP
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:DCP has been successfully added to your 
